Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

Clinical trial NCT01015222 · COMPLETED

Trial details

NCT number: NCT01015222
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2009-11-01
Primary completion: 2021-05-27
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.